← Back to all trials
Recruiting
NCT05607576
Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients
Conditions: Diabetes
Sex: All
Ages: 11 Years – 25 Years
Phase: NA
Enrollment: 40
Sponsor: Deborah Elder
Location: United States
Summary
A single-center prospective trial on the effects of standard of care radiation exposure on the Dexcom G6 continuous glucose monitoring (CGM) device.
Eligibility Criteria
Inclusion Criteria:Planned TPIAT at CCHMCStaying in-patient at CCHMC post TPIATPlanned to receive a Dexcom G6 CGMExclusion Criteria:• Hemo- or peritoneal dialysis
Source: ClinicalTrials.gov (NCT05607576). StuddyBuddy aggregates publicly available trial information.